Lenders, insurers, asset managers and the plumbing of the financial system.
85 report(s) in the archive
The derivatives regulator moved to cover exchanges and crypto activity even as a separate agency scrapped digital-asset guidance for banks.
The CFTC proposed two new rules covering crypto exchanges and trading activity, while a separate US regulator withdrew its digital-asset rules for banks, continuing a broader pullback in crypto oversight.
Warsh described the Fed's move as removing 'a dose of accommodation,' language that raises the question of whether further hikes are coming this year.
Fed Chair Kevin Warsh characterized the central bank's first rate hike since 2023 as removing "a dose of accommodation," a phrase that signals a shift toward tighter monetary policy.
The bank's forecast implies further dollar strength against the euro through the end of 2026.
Bank of America projects the euro will fall to $1.15 against the dollar by the end of 2026, citing broader market risks.
Logan said the Fed needs to raise rates by '50 basis points or more' to tame inflation that remains stubbornly high.
Dallas Fed President Lorie Logan said the central bank needs to raise interest rates by at least 50 basis points to curb inflation that has proven more persistent than expected.
The bank also raised its ether target to $3,028 from $2,240, citing renewed inflows into crypto exchange-traded funds.
Citigroup raised its 12-month bitcoin price target to $113,000 and its ether target to $3,028, pointing to the resumption of ETF inflows as the catalyst.
The bank initiated coverage on five major homebuilders in a single day, backing Toll Brothers and PulteGroup while flagging margin and supply risks at Lennar and NVR.
Morgan Stanley initiated overweight ratings on Toll Brothers and PulteGroup (with a $128 target) while rating Lennar and NVR underweight on margin and lot-supply concerns, and D.R. Horton equalweight.
Pre-IPO derivatives barely moved on the AI lab's prospectus even as Nvidia turns to insurers to offload build-out risk.
Anthropic's prospectus disclosed plans to spend $518 billion on AI infrastructure despite heavy losses, yet pre-IPO perpetual futures on crypto exchanges barely moved.
Investors trimmed risk exposure across the region on September 28 as they waited to see whether Australia's central bank would hold or move on rates.
Asian equity markets fell in the September 28 session as rising government bond yields and higher oil prices pushed investors toward safer assets ahead of the Reserve Bank of Australia's rate decision.
Interest from outside suitors comes as UBS and Swiss regulators continue to negotiate capital rules following the Credit Suisse takeover.
A Swiss newspaper reported that foreign banks have expressed interest in a potential merger with UBS, though no details on which institutions or what terms were disclosed.
The bank cited improving deleveraging outlooks and commodity price sensitivity as oil prices eased through the week.
HSBC upgraded BP and TotalEnergies to Buy and raised its Chevron price target to $250, reshuffling its oil major ratings as crude prices softened.
Policymakers tweaked forward guidance rather than moving rates, signaling less certainty about the pace of future cuts.
Banxico left its benchmark interest rate unchanged at 6.5% and adjusted its forward guidance, citing persistent core inflation.
The same session that pushed private-equity and regional-bank shares to fresh lows sent lab-equipment and manufacturing names to records, underscoring a split market.
Carlyle Group fell to a 52-week low of $39.15 and First Citizens BancShares to $19.56, while Thermo Fisher Scientific hit a 52-week high of $671.69 and Xometry an all-time high of $107.00.
Bank of England's Lombardelli flagged rising odds of a rate hike while Sweden's Riksbank held rates but pointed to hikes later this year.
Bank of England policymaker Clare Lombardelli said the odds of a rate hike are rising as oil prices stay elevated, while Sweden's Riksbank held its rate at 1.75% but signaled hikes later this year.
The bank started coverage of the pulmonary-disease drugmaker with a Sell while giving fellow gene-therapy name MeiraGTx a Neutral.
Goldman Sachs opened coverage on United Therapeutics with a Sell rating, a rare bearish call on a biotech that has built a lucrative franchise in pulmonary arterial hypertension drugs.
The bank shifted the gathering to London as the conflict continues to weigh on expatriate operations in the Gulf.
HSBC moved a scheduled board meeting from Dubai to London, with the Financial Times reporting the decision reflects ongoing safety concerns tied to the Iran war.
The deal news coincided with a broader tech rotation that pulled capital away from bank stocks.
PayPal shares rose after news of an AI partnership with Meta, a move that coincided with investors rotating out of financial stocks and into tech names.
UBS stock fell in the same session the Swiss bank disclosed cutting its holding in RC Fornax below the regulatory reporting threshold and addressed capital pressure at a Bank of America financials conference.
UBS stock declined on September 22 as the bank disclosed a reduced stake in RC Fornax and discussed capital pressure at an industry conference.
The bank lowered its year-end target to 7,700 just as separate data show valuations at levels last seen 26 years ago.
Wells Fargo cut its S&P 500 target to 7,700 and warned of 5%-10% near-term downside, adding to signs that stretched valuations are drawing scrutiny.
The People's Bank of China left its benchmark loan prime rates unchanged in September, extending a freeze that has now run over a year.
China's central bank kept benchmark lending rates unchanged for the 16th consecutive month in September, citing narrowing room for further monetary easing.
Bank of America issued a warning tied to the Federal Reserve's latest rate increase, even as commentary turned to its effect on consumer shopping.
Bank of America issued a warning about the Federal Reserve's rate-hike path, coming alongside separate reporting on how the increase could affect holiday shopping.